Saturday 17 October 2026
Export TCMD’s income statement to Excel — free account
Tactile Systems Technology, Inc.
TCMD Healthcare Medical Devices
Tactile Systems Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $329.5 million, up 12.5% from fiscal 2024. In the quarter to June 2026, revenue grew 8.61%, EPS grew 142.9% and free cash flow fell 86.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
22.52
0.77
−3.31%
Follow TCMD
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
297.35 | 87.00 | 124.05 | 116.40 | 0.00 | 0.00 | 0.00 | 11.81 | 24.47 | 34.12 |
Piotroski F-Score |
6 | 6 | 5 | 3 | 3 | 3 | 4 | 7 | 6 | 8 |
Altman Z-Score |
8.24 | 21.55 | 30.36 | 21.93 | 12.41 | 3.20 | 2.05 | 3.97 | 4.97 | 9.61 |
P/S ratio |
1.66 | 4.70 | 5.78 | 6.74 | 4.65 | 1.80 | 0.96 | 1.19 | 1.40 | 2.01 |
Altman Z″-Score (non-manufacturers) |
9.12 | 9.91 | 9.97 | 7.69 | 6.54 | 3.35 | 1.92 | 5.40 | 6.70 | 8.52 |
P/FCF ratio |
22.59 | 1,380.00 | 0.00 | 0.00 | 1,728.54 | 1,359.61 | 72.06 | 9.78 | 10.72 | 16.47 |
Beneish M-Score |
(2.67) | (2.16) | (1.94) | (1.91) | (2.30) | (2.36) | (2.90) | (2.64) | (2.88) | (2.82) |
P/Operating CF |
51.89 | 123.43 | 156.19 | 14,350.81 | 172.55 | 66.94 | 61.69 | 17.79 | 25.05 | 38.35 |
P/B ratio |
2.35 | 7.05 | 9.31 | 11.34 | 6.97 | 2.93 | 1.96 | 1.69 | 1.89 | 3.03 |
Price to Tangible BV |
2.44 | 7.27 | 9.91 | 11.91 | 7.06 | 8.71 | 5.95 | 2.82 | 2.87 | 4.46 |
EV/Sales |
1.16 | 4.30 | 5.46 | 6.54 | 4.44 | 1.86 | 1.00 | 1.01 | 1.10 | 1.78 |
EV/EBITDA |
19.37 | 81.69 | 118.57 | 90.25 | 0.00 | 201.32 | 0.00 | 11.29 | 11.16 | 16.31 |
EV/Operating CF |
13.97 | 111.99 | 87.21 | 493.62 | 297.17 | 146.84 | 47.16 | 7.74 | 7.96 | 13.68 |
EV/FCF |
15.86 | 1,261.97 | (1,457.41) | (356.23) | 1,650.65 | 1,399.75 | 74.44 | 8.31 | 8.48 | 14.55 |
Quick Ratio |
4.11 | 4.38 | 4.48 | 4.05 | 3.83 | 2.62 | 1.44 | 2.88 | 3.78 | 3.49 |
Current Ratio |
4.66 | 5.29 | 5.29 | 5.06 | 4.63 | 3.29 | 1.86 | 3.54 | 4.36 | 4.03 |
Net Debt/EBITDA |
(8.22) | (7.64) | (6.93) | (2.79) | 42.35 | 5.77 | (1.21) | (2.00) | (2.96) | (2.76) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 9.97% | 11.14% | 21.20% | 18.00% | 9.30% | 7.79% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.13 | 0.16 | 0.40 | 0.38 | 0.14 | 0.11 | 0.00 |
Asset Turnover |
1.52 | 1.35 | 1.47 | 1.46 | 1.15 | 0.99 | 0.99 | 1.02 | 1.01 | 1.15 |
Operating CF/Net income |
4.31 | 0.72 | 1.36 | 0.23 | (4.51) | (0.22) | (0.29) | 1.26 | 2.40 | 2.24 |
Capex/Depreciation |
(1.04) | (2.07) | (2.63) | (1.85) | (0.85) | (0.64) | (0.30) | (0.38) | (0.37) | (0.38) |
Interest Coverage |
— | — | — | — | — | — | (4.58) | 4.35 | 10.64 | 28.21 |
| 6.05% | 8.84% | 8.17% | 10.87% | (0.52%) | (9.34%) | (14.31%) | 18.10% | 8.27% | 8.77% | |
| 2.94% | 7.21% | 6.77% | 8.48% | (0.38%) | (5.65%) | (7.16%) | 10.63% | 5.85% | 6.67% | |
ROIC |
14.88% | 8.44% | 4.31% | 8.83% | (2.65%) | (0.79%) | (6.17%) | 7.80% | 10.59% | 15.29% |
Return on Tangible Assets |
3.14% | 8.85% | 8.99% | 11.63% | (0.60%) | (13.76%) | (29.05%) | 25.82% | 11.90% | 14.76% |
Average Days of Receivables |
64.77 | 65.94 | 66.33 | 64.42 | 85.53 | 86.80 | 81.09 | 57.42 | 55.98 | 48.60 |
Research and Development Expense of Revenue |
5.29% | 4.63% | 3.68% | 2.73% | 2.81% | 2.72% | 2.87% | 2.85% | 3.01% | 2.57% |
Selling, General and Administrative Expense of Revenue |
62.52% | 65.25% | 65.38% | 62.47% | 69.99% | 69.01% | 67.76% | 61.65% | 62.51% | 63.71% |
Intangible Assets out of Total Assets |
0.03 | 0.03 | 0.05 | 0.04 | 0.01 | 0.35 | 0.32 | 0.28 | 0.25 | 0.26 |
Share Based Compensation of Revenue |
2.23% | 3.88% | 5.55% | 5.18% | 5.71% | 4.89% | 3.89% | 2.75% | 2.67% | 2.54% |
Graham Net Nets |
0.36 | 0.12 | 0.08 | 0.05 | 0.09 | (0.01) | (0.06) | 0.18 | 0.24 | 0.17 |
Graham Number |
2.82 | 5.66 | 6.36 | 8.81 | 0.00 | 0.00 | 0.00 | 15.14 | 11.95 | 13.53 |
Earnings Yield |
0.34% | 1.15% | 0.81% | 0.86% | (0.11%) | (3.15%) | (7.51%) | 8.47% | 4.09% | 2.93% |
Free Cash Flow Yield |
4.43% | 0.07% | (0.06%) | (0.27%) | 0.06% | 0.07% | 1.39% | 10.22% | 9.33% | 6.07% |
Revenue per Share |
9.49 | 6.30 | 7.88 | 10.02 | 9.67 | 10.55 | 12.30 | 11.97 | 12.27 | 14.41 |
Operating CF per Share |
0.79 | 0.24 | 0.49 | 0.13 | 0.14 | 0.13 | 0.26 | 1.56 | 1.70 | 1.87 |
Capex per Share |
(0.09) | (0.22) | (0.52) | (0.32) | (0.12) | (0.12) | (0.10) | (0.11) | (0.10) | (0.11) |
Free Cash Flow per Share |
0.70 | 0.02 | (0.03) | (0.18) | 0.03 | 0.01 | 0.16 | 1.46 | 1.60 | 1.76 |
Cash per Share |
4.68 | 2.53 | 2.51 | 2.82 | 3.03 | 2.06 | 1.90 | 3.28 | 4.56 | 4.34 |
Shareholders Equity per Share |
6.69 | 4.19 | 4.89 | 5.95 | 6.45 | 6.50 | 6.05 | 8.45 | 9.07 | 9.57 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
6.69 | 4.19 | 4.89 | 5.95 | 6.45 | 6.50 | 6.05 | 8.45 | 9.07 | 9.57 |
Free Cash Flow |
6.20 | 0.37 | (0.54) | (3.48) | 0.50 | 0.28 | 3.30 | 33.37 | 38.16 | 40.28 |
Working Capital |
50.44 | 62.35 | 68.89 | 86.91 | 96.90 | 79.09 | 55.43 | 104.24 | 136.86 | 124.21 |
Capital Expenditures |
(0.83) | (3.82) | (9.55) | (5.99) | (2.29) | (2.35) | (1.91) | (2.48) | (2.50) | (2.53) |
Net Current Asset Value |
49.94 | 61.21 | 67.16 | 69.18 | 74.28 | (2.50) | (13.83) | 57.50 | 96.24 | 110.13 |
EV/EBIT |
23.00 | 120.43 | 262.72 | 118.02 | 0.00 | 0.00 | 0.00 | 15.38 | 14.58 | 20.01 |
Capex to Sales |
0.01 | 0.04 | 0.07 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Price to Operating Income |
32.76 | 131.70 | 278.07 | 121.66 | 0.00 | 0.00 | 0.00 | 18.10 | 18.45 | 22.66 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.51 | 0.49 | 0.76 | 0.44 | 0.39 | 0.55 | 1.03 | 1.06 | 1.21 | 1.30 |
Cash ROIC |
6.12% | 0.32% | (0.40%) | (1.92%) | 0.25% | 0.13% | 1.61% | 11.31% | 10.94% | 12.66% |
Accounts Receivable Turnover |
5.80 | 6.29 | 6.27 | 6.36 | 4.84 | 4.46 | 4.73 | 5.60 | 6.65 | 7.42 |
Accounts Payable Turnover |
6.45 | 7.23 | 8.86 | 12.34 | 13.51 | 12.98 | 9.44 | 9.53 | 12.40 | 14.95 |
Inventory Turnover |
3.72 | 3.30 | 3.73 | 3.65 | 2.89 | 3.17 | 3.34 | 3.47 | 3.70 | 4.86 |
Average Days of Payables |
60.08 | 53.50 | 44.95 | 25.39 | 28.20 | 30.64 | 51.46 | 30.65 | 27.02 | 22.84 |
Days of Inventory on Hand |
104.28 | 138.88 | 98.43 | 125.90 | 124.73 | 117.21 | 119.20 | 103.70 | 89.30 | 64.49 |
Average Receivables |
14.58 | 17.37 | 22.93 | 29.78 | 38.65 | 46.66 | 52.15 | 49.00 | 44.06 | 44.41 |
Average Payables |
3.56 | 4.01 | 4.68 | 4.48 | 4.02 | 4.61 | 7.50 | 8.32 | 6.15 | 5.31 |
Average Inventory |
6.17 | 8.80 | 11.11 | 15.12 | 18.81 | 18.89 | 21.17 | 22.83 | 20.60 | 16.35 |
Average Assets |
55.45 | 81.19 | 97.76 | 129.41 | 162.92 | 209.18 | 249.63 | 268.22 | 289.68 | 285.93 |
Average Common Equity |
27.00 | 66.21 | 81.03 | 100.93 | 118.67 | 126.49 | 124.81 | 157.52 | 205.12 | 217.75 |
Columns are period end dates